Clinical Trial Update: A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study [Phase 3]

View source ↗

Summary

This clinical trial update notes that the Phase 3 ASSET study in patients with pulmonary hypertension associated with sickle cell disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension
• Sickle Cell Disease

Snippet

Sponsor: Actelion | Conditions: Pulmonary Hypertension, Sickle Cell Anemia | Phase 3 | Status: TERMINATED